| Pneumonia and Respiratory Infections | Lifetime | 9 | ZA 1 | 99.90 |
| Respiratory viral infections research | Lifetime | 12 | ZA 1 | 99.88 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 13 | ZA 1 | 99.81 |
| Neonatal and Maternal Infections | Lifetime | 11 | ZA 1 | 99.63 |
| Vaccine Coverage and Hesitancy | Lifetime | 29 | ZA 3 | 99.53 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 99 | ZA 3 | 99.48 |
| COVID-19 Clinical Research Studies | Lifetime | 113 | ZA 2 | 99.33 |
| Influenza Virus Research Studies | Lifetime | 50 | ZA 1 | 99.63 |
| Streptococcal Infections and Treatments | Lifetime | 71 | ZA 2 | 99.38 |
| Bacterial Infections and Vaccines | Lifetime | 60 | ZA 2 | 99.29 |
| Viral gastroenteritis research and epidemiology | Lifetime | 173 | ZA 1 | 99.28 |
| COVID-19 Impact on Reproduction | Lifetime | 41 | ZA 1 | 98.49 |
| Viral Infections and Immunology Research | Lifetime | 197 | ZA 1 | 98.63 |
| Tuberculosis Research and Epidemiology | Lifetime | 447 | ZA 38 | 98.39 |
| Tracheal and airway disorders | Lifetime | 607 | ZA 1 | 98.07 |
| Neonatal Respiratory Health Research | Lifetime | 774 | ZA 3 | 98.13 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 668 | ZA 6 | 97.39 |
| COVID-19 epidemiological studies | Lifetime | 487 | ZA 7 | 96.71 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 371 | ZA 3 | 96.48 |
| Virology and Viral Diseases | Lifetime | 646 | ZA 2 | 95.59 |
| Immune responses and vaccinations | Lifetime | 467 | ZA 14 | 88.66 |
| Autopsy Techniques and Outcomes | Lifetime | 971 | ZA 14 | 81.20 |
| Pneumonia and Respiratory Infections | 2021-2025 | 3 | ZA 1 | 99.81 |
| Respiratory viral infections research | 2021-2025 | 4 | ZA 2 | 99.80 |
| COVID-19 Clinical Research Studies | 2021-2025 | 53 | ZA 2 | 99.61 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 47 | ZA 2 | 99.69 |
| Neonatal and Maternal Infections | 2021-2025 | 2 | ZA 1 | 98.52 |
| COVID-19 Impact on Reproduction | 2021-2025 | 22 | ZA 1 | 98.34 |
| Streptococcal Infections and Treatments | 2021-2025 | 15 | ZA 1 | 98.14 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 81 | ZA 2 | 98.37 |
| Neonatal Respiratory Health Research | 2021-2025 | 117 | ZA 2 | 98.00 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 137 | ZA 2 | 96.60 |
| COVID-19 epidemiological studies | 2021-2025 | 295 | ZA 7 | 96.07 |
| Bacterial Infections and Vaccines | 2021-2025 | 106 | ZA 2 | 92.71 |
| Influenza Virus Research Studies | 2021-2025 | 283 | ZA 5 | 93.57 |
| COVID-19 and healthcare impacts | 2021-2025 | 823 | ZA 5 | 90.04 |
| Congenital Diaphragmatic Hernia Studies | 2021-2025 | 274 | ZA 2 | 90.81 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 365 | ZA 35 | 87.60 |
| vaccines and immunoinformatics approaches | 2021-2025 | 538 | ZA 13 | 81.37 |
| Parvovirus B19 Infection Studies | 2021-2025 | 285 | ZA 1 | 75.87 |
| HIV/AIDS Impact and Responses | 2021-2025 | 303 | ZA 83 | 70.22 |
| Autopsy Techniques and Outcomes | 2021-2025 | 693 | ZA 12 | 54.78 |
